Alltius provides an agentic AI platform that automates voice and chat interactions for financial services firms, ingesting their knowledge bases and compliance rules to deliver accurate support and personalized sales pitches. The secure, full‑stack solution integrates with existing CRM and contact‑center systems, offering real‑time analytics and workflow orchestration to reduce support costs and boost conversion rates while meeting industry security standards.

EarthSense develops AI-powered robots for the agricultural sector that automate the planting of cover crops, enhancing soil health and increasing crop yields. This technology addresses labor shortages and reduces chemical costs, enabling farmers to improve profitability while contributing to climate change mitigation through carbon credit generation.

Elucidata provides Polly, a cloud‑based, no‑code platform that automates the integration, harmonization, and analysis of large biomedical omics and clinical datasets. By offering scalable AWS compute, built‑in quality control, AI/ML tools, and an integrated knowledge graph, Polly enables pharma and biotech R&D teams to accelerate hypothesis testing, patient stratification, and target discovery while reducing manual bioinformatics effort and costs.

The startup has developed a single-use disposable fluid therapy device that prevents accidental disconnection of IV medications by incorporating dual check valves and filtration to eliminate microbes and particulates. This technology enhances patient safety by reducing the risk of bloodstream infections during intravenous fluid management.

Heal is a nonprofit ecommerce platform that utilizes experience-based peer support to help individuals with mental illness reconnect with their passions through creative expression. By empowering emerging artists to showcase their work, Heal reinvests 100% of its profits into community-building initiatives that foster meaningful connections.

Healionics develops the _STARgraft_ synthetic vascular graft, which utilizes a Sphere Templated Angiogenic Regeneration biomaterial to enhance blood access for dialysis patients. This technology significantly reduces the risks of occlusion and infection associated with traditional grafts, improving patient outcomes and lowering treatment costs.

Provides an external data management platform that centralizes, cleanses, and enriches third-party data for enterprises, ensuring it is accurate and up-to-date. By integrating with systems like Databricks and automating data stewardship, it reduces manual processes by over 80% and mitigates the financial impact of poor data quality, which can cost companies 15% to 25% of revenue.

Nektar offers an AI‑driven platform that automates the simulation of drug‑target interactions and pharmacokinetic properties, delivering efficacy, safety, and ADMET predictions in minutes. Users upload molecular structures and receive ranked candidate lists, binding affinity estimates, and detailed pharmacology reports via a web dashboard, with API and export options for seamless integration into drug‑discovery pipelines.

Uses real-time market and geospatial data to identify and recommend land development opportunities nationwide based on custom criteria. The platform streamlines site selection by analyzing parcels, listings, and permit activity, enabling developers to discover optimal sites faster and increase deal flow.

Spyne provides AI-powered tools for automotive dealerships to enhance vehicle merchandising and customer engagement. Their platform offers solutions for automated image cataloging, 360-degree car tours, and AI agents to manage sales and service interactions. This technology streamlines operations and improves the digital presentation of vehicle inventory for dealers and marketplaces.

THB is a healthcare data-technology platform that utilizes big data analytics to generate real-world clinical evidence and enhance patient care through a 360-degree Care Engine. By processing over 1 billion clinical parameters, THB enables healthcare enterprises to deliver hyper-personalized treatment recommendations and improve decision-making for over 20 million patients.

The startup has developed a handheld device that utilizes non-invasive imaging technology to assess the malignancy of skin growths, providing objective evaluations by non-specialist frontline caregivers. This low-cost solution enables early detection of skin cancer, improving patient outcomes by facilitating timely treatment.

WEVO is a unified platform that combines AI‑driven visual heatmaps, friction scores, and rapid prototype testing with optional human‑validated studies. Users upload designs, prototypes, live sites, or competitor pages and receive instant AI insights in minutes or deeper qualitative feedback from real participants within days, enabling marketers, designers, product and growth teams to validate concepts, optimize conversion funnels, and iterate quickly without exceeding budget.